FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377197003: Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3501592019 Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676824014 Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1202513019 Aspirin + caffeine + orphenadrine citrate 428mg/30mg/25mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215424017 Aspirin + caffeine + orphenadrine citrate 428mg/30mg/25mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1478573012 Aspirin+caffeine+orphenadrine citrate 428mg/30mg/25mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3490397011 Product containing aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3494173015 Product containing aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501592019 Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569130010 Product containing only aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569131014 Product containing only aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676824014 Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676825010 Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Aspirin compound preparation (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Product containing caffeine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Aspirin + caffeine + orphenadrine citrate tablet false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bronchodilator false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Stimulant (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Orphenadrine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phosphodiesterase inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Orphenadrine citrate false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Product containing aspirin and caffeine and orphenadrine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Oral aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Orphenadrine-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Oral caffeine (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Orphenadrine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator value 25 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Caffeine false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator value 30 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator value 428 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Caffeine false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator value 30 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Orphenadrine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Orphenadrine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator value 25 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has presentation strength numerator value 428 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Product containing aspirin and caffeine and orphenadrine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient Orphenadrine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient Caffeine false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Is a Product containing only aspirin and caffeine and orphenadrine in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Orphenadrine citrate true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient Aspirin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient Orphenadrine citrate true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Caffeine true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has precise active ingredient Caffeine true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has basis of strength substance (attribute) Aspirin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start